Skin News and Research

RSS

Researchers reveal how stress conditions favor lytic reactivation of herpesviruses

Hiding their DNA genome inside the nucleus of the infected cells, the herpesviruses establish a lifelong infection in humans. Not well defined stress conditions are known to wake up these parasites from their dormancy - the latent phase - and reactivate the production of new viral progeny, eventually causing cell death by lysis - the lytic phase.

25 Feb 2016

Study: Magnesium therapy can alleviate muscular symptoms in patients with Motor Neurone Disease

Around 5,000 Motor Neurone Disease (MND) sufferers across the UK could find relief to their muscular symptoms thanks to transdermal (through the skin) magnesium therapy, say health pioneers BetterYou.

From BetterYou Ltd 25 Feb 2016

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

24 Feb 2016

Study reveals role of 'Kurly' protein found in cilia

A new study of a protein found in cilia - the hair-like projections on the cell surface - may help explain how genetic defects in cilia play a role in developmental abnormalities, kidney disease and a number of other disorders.

24 Feb 2016

MDI Biological Laboratory scientist identifies potential drug therapy to reverse peripheral nerve damage

The Mount Desert Island Biological Laboratory has announced that assistant professor Sandra Rieger, Ph.D., has identified two drugs that could potentially be used to reverse peripheral nerve damage, or peripheral neuropathy, resulting from chemotherapy treatment for ovarian, breast, lung, pancreas and other cancers. The drugs also have potential applications for the treatment of peripheral nerve damage caused by diabetes, traumatic injuries and other conditions.

23 Feb 2016

How to avoid breast damage when exercising: an interview with Professor Joanna Scurr

The breast itself doesn't contain any muscles and the only 2 supporting structures are the skin and the Cooper’s ligaments. Both of those structures are quite weak mechanically so they're not able to hold the breast in place firmly.

23 Feb 2016

People diagnosed with depression find difficult to stop smoking

People diagnosed with depression are about twice as likely to smoke as the general population. A survey of 6811 participants from Australia, Canada, the United Kingdom, and the USA, published today in the scientific journal Addiction, found that although depressed smokers tried to quit smoking more often than other smokers, they were more likely to return to smoking within a month.

22 Feb 2016

Researchers analyze how Topo II enzyme may affect stability of genomes

While researchers are now familiar with how cancer begins—cells mutate and then multiply wildly out of control—it is still uncertain exactly how that mutation starts in the molecules of the cells.

22 Feb 2016

New molecular delivery system could help ensure delivery of chemotherapy drugs into tumours

Chemotherapy isn't supposed to make your hair fall out -- it's supposed to kill cancer cells. A new molecular delivery system created at U of T Engineering could help ensure that chemotherapy drugs get to their target while minimizing collateral damage.

22 Feb 2016

New study focuses on safety of using induced pluripotent stem cells in patients

A new study led by scientists at The Scripps Research Institute and the J. Craig Venter Institute shows that the act of creating pluripotent stem cells for clinical use is unlikely to pass on cancer-causing mutations to patients.

22 Feb 2016

Amarantus BioScience Holdings closes $3M investment

Amarantus BioScience Holdings, Inc., a biotechnology company developing products in Regenerative Medicine, Neurology and Orphan diseases, today announced the closing of a $3M investment from an institutional investor. Under the terms of the agreement, the investor will be issued $3.3M worth of Series H Convertible Preferred Stock (including 10% original issue discount) from the Company and five year warrants exercisable for 13,200,000 shares of common stock at $0.40 per share.

22 Feb 2016

New approach could open door to more personalized medications for diabetes patients

New research from the University of Copenhagen points to an entirely new approach for designing insulin-based pharmaceuticals. The approach could open the door for more personalized medications with fewer side effects for Type 1 Diabetes patients.

19 Feb 2016

Stem cell research reveals how Parkinson’s spreads from cell to cell

Stem cell research published today offers up new clues as to how Parkinson’s spreads from cell to cell, a process which has evaded researchers for decades.

19 Feb 2016

Magnesium therapy as a relaxing Mother’s day gift

This Mother’s Day, give the most important woman in your life one of the most powerful mineral relaxation rituals – magnesium therapy.

From BetterYou Ltd 17 Feb 2016

BD announces FDA clearance and European CE marking for new safety blood collection set

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and European CE marking for a new safety blood collection set – the BD Vacutainer UltraTouch Push Button Blood Collection Set – that uses proprietary needle technology to help enhance the patient experience during this important procedure.

17 Feb 2016

Simulation training for prenatal and neonatal emergencies

It's difficult to practice skills on preterm babies who are in neonatal intensive care units (NICU). The complications associated with preterm babies can be varied and infrequent, making it hard for staff to develop their skills set.

From Laerdal 17 Feb 2016

Long-term survival of 'blue babies' and patients with congenital heart defects reasonably good

Over 90 percent of those operated on for congenital heart defects as children, for example, due to blue baby syndrome, are alive 20 years post-surgery. A new doctoral thesis at Sahlgrenska Academy has explored this issue.

17 Feb 2016

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Allergan plc today announced the U.S. Food and Drug Administration has accepted for filing the company's supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil).

16 Feb 2016

NICE issues positive guidance for use of Medtronic insulin therapy systems for managing Type 1 diabetes

Today, the United Kingdom’s National Institute for Health and Care Excellence has issued positive guidance for the use of Medtronic insulin pump systems integrated with glucose sensors, for managing Type 1 diabetes and the avoidance of potentially life-threatening hypoglycemic episodes.

16 Feb 2016

Wake Forest Baptist scientists prove feasibility of printing living tissue structures for surgical implantation

Using a sophisticated, custom-designed 3D printer, regenerative medicine scientists at Wake Forest Baptist Medical Center have proved that it is feasible to print living tissue structures to replace injured or diseased tissue in patients.

15 Feb 2016

Skin News and Research

Researchers reveal how stress conditions favor lytic reactivation of herpesviruses

Study: Magnesium therapy can alleviate muscular symptoms in patients with Motor Neurone Disease

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Study reveals role of 'Kurly' protein found in cilia

MDI Biological Laboratory scientist identifies potential drug therapy to reverse peripheral nerve damage

How to avoid breast damage when exercising: an interview with Professor Joanna Scurr

People diagnosed with depression find difficult to stop smoking

Researchers analyze how Topo II enzyme may affect stability of genomes

New molecular delivery system could help ensure delivery of chemotherapy drugs into tumours

New study focuses on safety of using induced pluripotent stem cells in patients

Amarantus BioScience Holdings closes $3M investment

New approach could open door to more personalized medications for diabetes patients

Stem cell research reveals how Parkinson’s spreads from cell to cell

Magnesium therapy as a relaxing Mother’s day gift

BD announces FDA clearance and European CE marking for new safety blood collection set

Simulation training for prenatal and neonatal emergencies

Long-term survival of 'blue babies' and patients with congenital heart defects reasonably good

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

NICE issues positive guidance for use of Medtronic insulin therapy systems for managing Type 1 diabetes

Wake Forest Baptist scientists prove feasibility of printing living tissue structures for surgical implantation

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News